ClinicalTrials.govpublic full text
Efficacy and Safety of Concurrent PD-1 Inhibitor and Radiotherapy With Immunonutrition for Esophageal Squamous Cell Carcinoma
locally advanced esophageal squamous cell carcinoma, sintilimab, radiotherapy, concurrent chemoradiotherapy, immunonutrition
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 226243
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.